出典: meddic


UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • The contribution of Raman spectroscopy to the analytical quality control of cytotoxic drugs in a hospital environment: eliminating the exposure risks for staff members and their work environment.
  • Bourget P1, Amin A2, Vidal F3, Merlette C3, Troude P4, Baillet-Guffroy A5.
  • International journal of pharmaceutics.Int J Pharm.2014 Aug 15;470(1-2):70-6. doi: 10.1016/j.ijpharm.2014.04.064. Epub 2014 May 2.
  • The purpose of the study was to perform a comparative analysis of the technical performance, respective costs and environmental effect of two invasive analytical methods (HPLC and UV/visible-FTIR) as compared to a new non-invasive analytical technique (Raman spectroscopy). Three pharmacotherapeutic
  • PMID 24792972
  • Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44).
  • Gerber B1, von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, Schrader I, Kittel K, Hanusch C, Solbach C, Jackisch C, Kunz G, Blohmer JU, Huober J, Hauschild M, Nekljudova V, Loibl S, Untch M.
  • Annals of surgical oncology.Ann Surg Oncol.2014 Aug;21(8):2517-24. doi: 10.1245/s10434-014-3606-9. Epub 2014 Apr 18.
  • PURPOSE: Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor, has shown increased pathological complete response rates when added to neoadjuvant chemotherapy. In various cancer types, bevacizumab treatment was accompanied by an increased risk of bleedings and othe
  • PMID 24740826
  • Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
  • Ju RJ1, Li XT1, Shi JF1, Li XY1, Sun MG1, Zeng F1, Zhou J1, Liu L1, Zhang CX1, Zhao WY1, Lu WL2.
  • Biomaterials.Biomaterials.2014 Aug;35(26):7610-21. doi: 10.1016/j.biomaterials.2014.05.040. Epub 2014 Jun 7.
  • Refractoriness of invasive breast cancer is closely related with the vasculogenic mimicry (VM) channels, which exhibit highly drug resistance to conventional chemotherapies. In the present study, the nanostructured targeting epirubicin plus celecoxib liposomes were developed by modifying a human imm
  • PMID 24912818


  • Reversible Cardiomyopathy After Epirubicin Administration
  • Koitabashi Norimichi,Ohyama Yoshiaki,Tateno Rieko,Arai Masashi,Rokutanda Nana,Horiguchi Jun,Kurabayashi Masahiko
  • International Heart Journal advpub(0), 2015
  • Epirubicin, which is widely used for breast cancer chemotherapy, is an anthracycline that has less cardiac toxicity than doxorubicin. … The present report describes the case of a 70-year-old woman with breast cancer who developed severe congestive heart failure and severe cardiac dysfunction at 6 weeks from epirubicin final administration. … To the best of our knowledge, this is the first report to describe epirubicin-induced subacute reversible cardiotoxicity. …
  • NAID 130005084046
  • 注射剤による血管障害の発現回避に向けた薬理学的検討並びに薬学的介入
  • 山田 孝明
  • 薬学雑誌. 乙号 135(3), 465-472, 2015
  • … Pharmaceutical intervention and pharmacological mechanisms used to reduce vascular injury induced by vinorelbine and epirubicin were reviewed. … On the other hand, the phlebitis scores were significantly higher in patients treated with epirubicin ready-to-use solution compared with lyophilized powder. … The change of formulation of epirubicin to lyophilized powder decreased the risk of venous irritation. …
  • NAID 130004756520
  • Epirubicinおよびtrastuzumab投与により心不全を呈した乳癌術後の1例
  • 木内 俊介,久武 真二,冠木 敬之 [他]
  • 循環器内科 76(4), 434-438, 2014-10
  • NAID 40020244509


エピルビシン(epirubicin, Epi-ADM)は、1975年にイタリアのファルミタリア カルロエルバ社(現:ファイザー株式会社)のF. Arcamoneらによって合成・開発された アントラサイクリン系の抗腫瘍性抗生物質製剤(抗がん剤)。塩酸塩が市販されており、 商品名は ...
Epirubicin should be administered only into a vein. However, it may leak into surrounding tissue causing severe irritation or damage. Your doctor or nurse will monitor your administration site for this reaction. If you experience any of the ...



拡張検索epirubicin hydrochloride



epirubicin EPI EPI-ADM
塩酸エピルビシン epirubicin hydrochloride
  • アントラサイクリン系抗腫瘍性抗生物質。


  • ファルモルビシン注射用10mg/ファルモルビシン注射用50mg



anthracycline, anthracyclines




epirubicin hydrochloride」